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Abstract 
Osteoporosis is characterised by reduced bone mass and aberrant bone micro-
architecture; thus increasing susceptibility to fracture due to reduced strength and quality. 
The aims of this study were to investigate the role of CXCR4 transfected on stem cell 
homing and osteogenic characteristics in osteopenic rats; particularly elucidating the effect 
on cell migration. 
Methods: MSCs were harvested from young, adult and ovarectomized animals and 
transfected with CXCR4; these cells were administered intravenously in ovarectomized 
rats. Micro CT and mechanical testing was completed after 12 weeks. 
Results: rats injected with young CXCR4 transfected cells had significantly higher BMD 
compared to placebo injected rats (p<0.05). Rats injected with ovarectomized CXCR4 
transfected cells, had higher BMD compared to those injected with saline or non-
transfected cells (p<0.04). L4 vertebral stiffness was significantly higher in rats treated with 
young CXCR4 transfected cells compared to all other groups (p<0.05). 
Conclusions:  CXCR4 genetically modified cells from young and ovarectomized sources 
improve some aspects of bone formation in the ovarectomized model of osteoporosis; and 
thus, may play a role in patient treatment regimens. 
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1.1 Introduction 
Post-menopausal oestrogen deficiency leads to an uncoupling of the bone remodelling 
cycle, whereby upregulated osteoclast activity, goes either unmatched or is coupled with 
aberrant osteoblast activity; thus leading overall net bone resorption. Defined as a skeletal 
disorder characterised by reduced bone strength and thus increased fracture risk (1); type 
one oestrogen deficient osteoporosis is a result of both a reduction in bone density and 
bone quality.  
Long term treatments aim to improve both bone strength and quality, be they anabolic or 
anti-catabolic in nature, interventions aim to in part restore a balance remodelling cycle 
(2); yet, as well as problems inherent to osteoporosis alone, the patient age will also 
hinder remodelling and regeneration efficacies. Bone formation may be compromised due 
to the number of mesenchymal stem cells (MSCs) within bone marrow diminishing with 
age (3-6), the ability of  these cells  to differentiate into osteoprogenitor cells and mature 
osteoblasts (7-10), and the ability of MSCs from aged sources to mobilise from their niche, 
home across the tissue endothelium and mature into active cell types that modulate the 
fracture environment. Bone healing following injury is in part modulated by quiescent 
MSCs at the fracture site, but also by the ability of latent cells to home/migrate to the site 
of injury; as such a number of preclinical studies have investigated the role of transplanted 
MSCs in fracture healing and in increasing bone mass (11). For a MSC transplantation to 
generate a clinical benefit, MSCs must engraft at the site of bone injury or the bone 
marrow. Chemokines play significant roles in controlling cellular migration; Granero-Molto 
identified the importance of the stromal derived factor-1/chemokine receptor type 4 (SDF-
1/CXCR4) axis in modulating cell migration from bone marrow. SDF-1/(11, 12). 
Transplantation of MSCs over-expressing RANK Fc(an antagonist of RANK L)  or CXCR4 (13) 
as well as, CXCR4 and Cbfa1 (14)  have been shown to restore bone mass and strength in 
osteopenic mice. In both these studies, MSCs were intravenously introduced into the mice 
through the tail vein, and MSCs over-expressing CXCR4 promoted in vivo cell trafficking to 
bone in OVX mice. This therapeutic effect of CXCR4 transfected MSCs therefore protects 
against bone loss and increases bone formation. 
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In this study we make a comparison of bone formation when MSCs from young rats and 
OVX rats transfected with CXCR4 as well as un-transfected OVX MSCs was used in an 
osteopenic rat model. The comparison between the two cell types investigates the 
beneficial effects of autologous cells from osteoporotic patients and may allude to the 
efficacy of CXCR4 modification in osteoporotic treatments;  as such, we hypothesis that 
CXCR4 transfected MSCs when administered intravenously, would migrate to the bone 
marrow and improve bone formation in an osteopenic rat model of osteoporosis.  
1.2 Methodology 
1.2.1 Animal model 
6 to 9-month old female ex-breeder wistar rats were purchased following ovariectomy. At 
16 weeks post-ovariectomy and following euthanasia, femoral bone mineral density was 
measured using peripheral quantitative computed tomography pQCT (Stratec XCT1000) to 
confirm osteopenia and this was compared with control non-ovariectomised rats. As such, 
cells from these animals were used experimentally at 10-13months 
1.2.2 Cell culture 
Rat bone marrow mesenchymal stem cells (rBMCs) were harvested from 2-4 week old 
young and the aforementioned ovariectomised Wistar rat femora (n=6 per group). Bone 
marrow cells were harvested by flushing the femora with Dulbecco's modified Eagle 
medium (DMEM), 20% fetal calf serum, 1% Penicillin Streptomycin (P/S) in a 25 cm2 flask. 
Cells were cultured at 37C at 5% CO2. Cells were characterised using tri-lineage 
differentiation and flow cytometry and used at passage 3. 
1.2.3 Preparation of the recombinant adenoviruses 
The human CXCR4 cDNA (pCMV-XL5-CXCR4 Origene) was digested by restriction 
endonucleases NotI and XhoI and then inserted into pShuttle-CMV (AdEasy XL Adenoviral 
vector system; Stratagene) to form pShuttle-CMV-CXCR4. The human CXCR4 gene and the 
pShuttle-CMV vector were both cut by restriction endonuclease NotI and XhoI and were 
then repaired to form blunt ends. Human CXCR4 cDNA was then cloned into the pShuttle-
CMV vector using DNA ligase. The presence of the insert was confirmed by restriction 
digest as well as Sanger sequencing. The incorporated shuttle vector was then linearised 
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with PmeI restriction endonuclease and transformed into BJ5183-AD-1 competent cells 
using electroporation. A scrambled plasmid was created by inserting no gene into the 
pShuttle-CMV vector.  
Following selection of the smallest colonies, the recombinant plasmid was collected and 
cut using the PacI restriction enzyme. The correctly identified copies were then largely 
expanded in bulk using the recombinant-deficient XL10-Gold strain. Purified recombinant 
plasmid DNA, cut with PacI was then used to transfect AD-293 cells. The viral particles 
were generated by alternate freezing and thawing of the infected AD293 cells and 
collecting the supernatant. An anti-hexon antibody stain was used to determine the plaque 
forming units/ml (pfu/ml) of the infected cells by counting the number of dark infected 
cells.  
1.2.4 Analysis of CXCR4 over-expression on infected cells 
Young and OVX MSCs from the third passage were infected with the CXCR4 adenovirus at a 
MOI of 800, trypsinised and centrifuged at 2000 rpm for 10 minutes before being 
resuspended at 100,000 cells in phosphate buffered saline (PBS). Cell aliquots were 
permeabilised in ice cold methanol for 10 minutes and incubated with primary CXCR4 
antibody (Abcam) for 1 hour at room temperature. The cells were washed in PBS and then 
incubated in secondary goat anti-rabbit antibody (Abcam) for 30 minutes at room 
temperature. The negative control consisted of cells incubated in the secondary antibody 
only. 100,000 cells were then analysed using a flow cytometry machine (Cytoflex, Beckman 
Coulter). The results were compared to uninfected MSCs from the same rats.   
1.2.5 Intravenous administration of CXCR4 transfected MSCs 
30 female ovariectomised rats (average weight 494.2±53.8 g) were injected with 0.5ml 
Sodium Nitroprusside (25mg/ml), followed by 1 million cells suspended in 2ml sterile saline 
and finally 0.2ml of saline to clear any cells left in the syringe. Successful injections were 
confirmed when the fluid was injected without any resistance and there was no swelling of 
the tail. The rats in this study were divided into two parts (Figure 6.1): 
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a. Cell tracker group: 6 rats were injected with Vybrant-1,1'-Dioctadecyl-3,3,3',3'-
Tetramethylindocarbocyanine Perchlorate (Dii) labelled cells (ThermoFisher
Scientific, UK). This group of rats was used to track the cells 7 days after injection in
order to illustrate effective mobilisation.. This was the ‘cell tracker group’ (Day 0
control rats). The rats were euthanised 7 days post-injection and the samples
retrieved from these rats were also used to obtain baseline histological,
micro/pQCT and mechanical data. The rats were divided into 2 groups:
 DiI labelled Young MSCs + Empty Plasmid (n=3)
 DiI labelled Young MSCs + CXCR4 (n=3)
To investigate the homing ability of MSCs, cells were labelled with DiI cell-labelling solution 
1x106 and plated in a T225 flask. 100ul of the DiI solution was suspended in 5ml of serum 
free media, cells were incubated in this for 30minutes at 37C.  
The rats were euthanised 7 days (Day 0 controls) post-injection and their femurs and tibias 
retrieved. The bone specimens were fixed in 10% buffered Formaldehyde, and decalcified 
in 12.5% ethylenediaminetetraacetic acid (EDTA), pH 8. Decalcification was confirmed by 
radiography, after which the specimens were dehydrated in increasing alcohol 
concentrations, treated with chloroform for 2 days to de-fat the tissue and then 
embedded in wax. Sections measuring 5µm thick were made using a microtome (Shandon 
Finesse 325, ThermoFisher Scientific, UK).  
Sections were de-waxed twice in xylene, placed in two changes of 100% alcohol and then 
hydrated in serial dilutions of alcohol. After hydration, samples were stained in 
haematoxylin, a nuclear stain, for 5-10 minutes. The excess stain was washed off by 
immersing the slides in water for 5 minutes. Samples were then differentiated in 0.5% HCL 
acid (made up in 70% alcohol) and washed using water. After removing the acid-alcohol, 
samples were counterstained in 1% eosin for 3-4 minutes, washed in water and 
dehydrated by serial dilutions of alcohol. Finally, samples were cleaned by xylene and 
mounted under coverslips using Pertex Mounting Medium (CellPath plc, UK). Samples 
were observed under a light microscope (KS-300 Zeiss, UK). This was used to observe the 
DiI labelled cells that had migrated to the bone (See section 6.2.6 below). The H&E images 
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observed under a light microscope allowed the location of the fluorescent cells to be 
identified in the bone. Slices were then imaged under a fluorescent microscope (Zeiss 
Apatome 2). The slides were stained with Hoechst 3342 (Thermofisher Scientific, UK) and 
mounted with FluoromountTM Aqueous Mounting Medium (Sigma Aldrich, UK) and viewed 
under an emission wavelength of 617nm.  
b. Experimental treatment group: OVX rats were divided into 4 groups; Groups A, B
and C were injected with cells and Group D received saline injection. The rats in this
group were euthanized after 11 weeks. The treatment groups were divided as
follows:
 Group A – Young MSCs + CXCR4 (n=6)
 Group B – OVX MSCs (n=6)
 Group C – OVX MSCs + CXCR4 (n=6)
 Group D – Saline (n=6)
From all the rats in both groups, the following samples were retrieved; the femora, tibiae, 
left humerus and L4 and L5 vertebrae for mechanical testing, micro CT and pQCT only..  
1.2.6 Vertebral compression 
L4 and L5 vertebra were separated from the rest of the vertebral column by halving the 
discs and cutting the ligaments. The facet joints and spinous processes were preserved to 
maintain physiological motion of the vertebrae during compression. Each vertebra was 
individually compressed at a speed of 0.75mm/min using a Zwick LFM machine, until 
failure and the ultimate compressive strength was measured.  
1.2.7 Three-point bending test of humerus, tibia and femur 
From the retrieved long bones all tissue and muscle attachments were cleared. The length 
of the bones was measured, the loading pin was set up at the bone’s mid shaft and the 
bones were loaded at a speed of 0.5mm/min using a Zwick LFM machine, until failure 
point when the bone fractured. The span between the two lower supports was set 10 mm 
apart. A force displacement graph was generated and used to calculate the stiffness and 
maximum load of the bones manually.  
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1.2.8   Peripheral Quantitative Computed Tomography (pQCT) of the tibia and femur 
The skin and soft tissue around the right and left femur were removed and BMD 
measured within the femoral condyles using pQCT (XCT 2000, Stratec, Pforzheim, 
Germany). The samples were fixed in formalin before scanning and were placed in a 
sealed 50ml Falcon tube during the scan. The total length of the bone was obtained prior 
to scanning and the femoral head of each sample was scanned symmetrically at slice 
intervals of 0.5mm. 3 slices were acquired at 10% and 1 slice was acquired at 20% (of the 
femoral length) from the proximal femur end. The samples were analysed using XCT 
software.  
1.2.9  MicroCT of the femoral metaphysis 
Samples were transported in PBS and wrapped in cling film for scanning (SkyScan 1172, 
Bruker, Belgium). The x-ray source was set at 70kV with a current of 120uA. To reduce 
beam hardening, a 0.5mm aluminium filter was used during the scan. During the scan a 
rotation degree of 0.6°, a frame averaging of 2 and a voxel size of 6um was applied. The 
NRecon software (Bruker, Belgium) was used to reconstruct the scanned images with the 
following parameters: smoothing = 2, beam hardening factor correction = 12% and ring 
artefact reduction = 41%.  
The trabecular bone was analysed using a CtAn software (Bruker, Belgium). The growth 
plate was selected as a reference point and a volume of 150 slices were selected, 200 
slices above the growth plate (Figure 2). For analysis, a volume of interest (VOI) was 
chosen by selecting the metaphyseal trabecular region and excluding the cortical bone and 
this region was used to measure the Bone Volume (BV) and Bone surface (BS).  
1.2.10 Statistical analysis 
The normality was checked using a Shapiro Wilkinson test and found to be non-
parametric; as such,  comparisons were made using a Mann-Whitney U test with a 
Bonferroni correction. All data was analysed using SPSS version 24 (Chicago, USA).  
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1.3 Results 
1.3.1 Establishment of the osteopenic rat model 
The mean femoral BMD measured in the OVX rat group was significantly lower (538.2 ± 
23.3g/cm3) when compared with control rats (666.9 ± 46 g/cm3) (p=0.0002).  BMD was 
seen to reduce by 19.3 ± 9%.  
1.3.2 CXCR4 expression of infected and uninfected cells 
After transfection with the CXCR4, 92±2.6% and 40±16.1% of young and OVX MSCs 
respectively over-expressed CXCR4. CXCR4 expression significantly increased (p=<0.05) 
from 19.4 ± 9.8% in non-transfected OVX cells to 40.0 ± 16.1% in transfected cells. In young 
MSCs CXCR4 expression only increased by 5% after transfection although non transfected 
young MSCs expressed high endogenous levels of CXCR4 (Figure 3).      
1.3.3 Fate of systemically injected MSCs 
At day 7, numerous DiI labelled nucleated cells were observed in the blood vessels in the 
cortical and trabecular bone of the femoral condyles, confirmed on H+E and fluorescent 
imaging (Figure 4). No fluorescent cells were visible in slides from rats that were injected 
with unlabelled cells. 
1.3.4 Vertebral compression 
The stiffness of the L4 vertebrae was significantly higher for the group that received the 
Young-CXCR4 MSCs (251.5 ± 61.7 N/mm) in comparison to the rats that received a sham 
saline injection (99.2 ± 16.2 N/mm) (Figure 5). 
1.3.5 Three-point bending test of the humerus, tibia and femur 
The stiffness of the humerus, tibia and femur were obtained by calculating the gradient of 
the force displacement graph. No significance difference was seen between the different 
groups. However, the rats receiving the saline injections had the lowest stiffness compared 
to those that received CXCR4-OVX MSCs and CXCR4-young MSCs.  
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1.3.6 PQCT of the tibia and femur 
Young MSCs transfected with CXCR4 significantly improved the BMD of the bone in the 
femoral condyles of the OVX rats. This significant difference in BMD was seen for the 
trabecular bone, cortical/subcortical bone and total BMD (Figure 6).  
There was no significant difference between OVX rats injected with young MSCs 
transfected with CXCR4 or injected with saline (transfected-trabecular BMD of 716.4 ± 
105.7 mg/ccm, total BMD of 694±80.1mg/ccm and Cort/sub cort BMD of 715.2 ± 45.4 
mg/ccm, saline-trabecular BMD of 535.5±61.6mg/ccm, 563.4±82.9mg/ccm and 576.2±11 
mg/ccm respectively. 
1.3.7 Micro CT and Histomorphometric Analysis of the metaphysis  
The effect of stem cell injection on the bone volume was subtle compared to saline 
injection but the groups injected with saline and the OVX group (the group prior to any 
intervention) showed fewer inter-connected trabeculae compared to the animals injected 
with transfected young stem cells (Figure 7).  
Rats treated with young-CXCR4 MSCs had the highest BS area (9.5x107 ± 5.3x107 µm2) 
compared to rats treated with OVX-CXCR4 MSCs (7.6x107 ± 5.0x107 µm2), OVX MSCs 
(7.1x107 ± 1.7x107 µm2) and saline (7.3x107 ± 5.5x107 µm2). As expected the Time 0 
controls had the highest bone surface area because they were euthanised 7-days post-
injection while the other groups of rats were euthanised 5-weeks post-injection. 
Of the experimental groups, rats injected with saline (p=0.03), OVX MSCs (p = 0.004) and 
OVX-CXCR4 (p = 0.02) MSCs had a significantly lower bone surface area compared to the 
rats injected with Young-CXCR4 MSCs (p = 0.07) (Figure 8). 
In all groups injected with stem cells bone volume (BV) was increased in comparison to 
saline injection. The rats treated with OVX-CXCR4 MSCs had the highest BV (1.7x 109 ± 1.4 
x 109 µm2) compared to rats treated with Young-CXCR4 MSCs (1.5 x 109 ± 7.0 x 108 µm2), 
OVX MSCs (1.4 x 109 ± 2.8 x 108 µm2) and saline (1.1 x 109 ± 8.5 x 108 µm2).  
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1.4 Discussion 
The hypothesis of this study was that CXCR4 transfected MSCs when administered 
intravenously, would migrate to the bone marrow and improve bone density and 
architecture.  In this paper we reinforced the effective migration of intravenously labelled 
MSCs to long bones, as well as the poor CXCR4 expression as well as migration of MSCs 
from OVX rat, we further demonstrated that injecting young MSCs transfected with CXCR4 
significantly enhanced BMD and L4 vertebral strength compared to rats who received 
placebo saline intravenously (Figures 5 and 6). It was also highlighted that injection of OVX 
and OVX-CXCR4 MSCs helped improve the BMD and trabeculae structure in the femoral 
condyles of the OVX rats compared to controls. These findings allude to possible 
applications of modified stem cells to enhance the bone properties in osteoporotic 
populations. The deteriorating changes of bone in the OVX rats injected with saline was 
reflected by the thinning of the trabeculae, reduced bone surface area and bone volume in 
the proximal femur. These micro-structural changes are common problems in osteoporotic 
patients, causing fragility fractures (15, 19). The small sample number of only 6 rats per 
group means that trends towards increased trabecular thickness in the femora of OVX rats 
injected with CXCR4 modified cells, were not clinically significant compared to untreated 
counterparts. Thus one wonders, if a larger number may actually prove significance, and 
thus add to the weight of evidence suggesting the utility of CXCR4 modification.  
The deteriorating bone structure of the OVX rat model was clearly observed as the Time 0 
control rats had the most bone volume and density compared to the rest of the OVX rats 
which were treated for a further 10 weeks. However, the rats injected with cells had a 
higher bone surface area and volume compared to the rats injected with saline. There was 
an increased BMD in the animals injected with cells using pQCT which seemed to 
contradict the modest increase in bone volume observed by microCT. This is similar to 
results by Huang and co-workers, 2016 that injected allogeneic MSCs from 8 week old rats 
into OVX rats and looked at their bone formation. They concluded that although the 
systemic transfusion of allogeneic MSC is a safe procedure, administering cells only may 
not be the most effective procedure for preventing osteoporosis. They also observed an 
increase in BMD using PQCT but no difference in trabeculae structure using microCT (20). 
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These differences could be because PQCT measures global bone formation while microCT 
is more specific as it measures slices specifically for analysing trabeculae structure. 
Regenerating the trabeculae to provide structural competence may not be difficult 
especially where continuity has been lost. Cunningham et al, 2005 investigated the 
recovery of the trabeculae in the right os-calcis in an ovine model. After removal of the 
trabeculae in the os-calcis animals were returned to their normal daily activities. However, 
the trabeculae did not regenerate and the os-calcis remained hollow but with increased 
density in the cortical bone. This could be because the load was distributed to the upper 
and lower beams of the bone, hence the increase in density and thickness of the cortical 
bone (21-23). Once interconnectivity between trabeculae has been compromised it is 
difficult to reform cross-links because of the mechanisms of load transfer which is altered 
due to reduced number of bridging elements.   
Injecting MSCs, irrespective of the fact that they were from OVX or young rats or 
uninfected or infected protected against bone loss associated with ovariectomy in rats 
compared to rats injected with saline. These results are similar to those reported by Lien 
and co-workers who injected CXCR4-infected cells in OVX rats and observed increased 
BMD in rats injected with cells compared to sham injections (13). However, they showed 
even more improved bone formation when they injected cells co-transfected with cbfa-1. 
Sheyn and co-workers, 2016 injected a combinational therapy of MSCs and PTH and 
showed that PTH aided with the migration of MSCs and also played an anabolic role in 
bone formation in vertebral defects in pigs (24). This highlights the importance of 
improving migration of cells and also stimulating their ability to form bone. It is important 
for cells to home and engraft into the marrow cavity (25) as well as help with the bone 
loss. Cho and co-workers, 2009 highlighted the role of transfecting the cells with RANK-Fc 
to improve the BMD in ovariectomised mice  and also improved their homing capability to 
the bone marrow (14, 25). Studies by Lien and Cho showed significantly improved BMD 
after injection of MSCs, however these results were based on pQCT data and unlike this 
work did not look at changes in the trabeculae using MicroCT. Additionally, they induced 
osteopenia in younger mice (around 3-4 months old) compared to this study where rats at 
Page 14 of 26 
14 
the time of experiments were upto 13months old; as such delineations are required 
between the sole effect of increased age as well as osteopenia.  
Although significant differences were seen in this study, there were a number of trends 
noted that were not significant. The number of significant differences seen in this study 
may have been increased by increasing the number of animals in each group.  
However, the novelty and significance of the work in this study is that it investigates the 
prospect of injecting autologous stem cells in osteoporotic patients. Injecting OVX-MSCs 
may not be as beneficial as injecting Young-MSCs or Young-CXCR4 MSCs, but we still 
found trends towards improvements in bone formation parameters with cells derived 
from ovarectomized rats. As such, our results indicate the possible clinical utility of stem 
cells from both young and osteopenic populations and may be further enhanced by the 
modification of CXCR4 expression. Further work is required to fully elucidate this effect, 
and should also assess in more detail the fate of injected cells-assessing the percentage 
retained at other sites through haematogenous spread. Ultimately, this work builds on 
the body of literature supporting stem cell use in bone regeneration and the promise 
modified cells provide  
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Figure 1: A schematic illustration showing the different groups of rats in the in vivo study. 
Cell tracker group (day 0 controls), were euthanised after 7 days, while the rest of the rats 
were euthanised after 11 weeks.  
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Figure 1: The sagittal, coronal and transaxial display of a reconstructed image of the 
growth plate, whereby a reference point was selected for analysis of bone morphometry. 
To avoid the growth plate, analysis was done 150 slices above the growth plate. 
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Figure 2:  FACS analysis of CXCR4 infected cells and uninfected cells of young MSCs (a); 
adult control (b) and OVX MSCs (c). The secondary isotype is represented by red, CXCR4 
expression in MSCs is represented by green and pink represents the CXCR4 over-
expression in the infected MSCs 
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Figure 3: DiI labelled cells located in the femur (A), H & E staining of these cells of wax 
histology slides of the femur (B & C).    
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Figure 4: The stiffness of the L4 and L5 vertebrae calculated from the gradient of the 
compression graph (n=6). Significant differences were found between Young-CXCR4 and 
Saline groups; as well as between Control and Saline groups. * shows significance p < 0.05 
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Figure 5: The mean BMD of the femur measured using PQCT. The BMD was measured for 
the femur and tibia and trabecular, cortical and total bone density was analysed for both 
bones. Difference was found between Young-CXCR4 and Saline groups in *trabecular 
bone, **cortical bone, **and for total bone density.  
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Figure 6: Three dimensional images of the femoral heads to illustrate the trabeculae 
structure of the metaphysis and epiphysis. 
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Figure 7: Bone Surface (µm2) of the femur obtained from rats treated with saline, OVX 
MSCs, OVX-CXCR4 MSCs and young CXCR4 MSCs. The error bars represent standard error 
of the mean. 
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Figure 8: Bone Volume (µm3) of the femur obtained from rats treated with saline, OVX 
MSCs, OVX-CXCR4 MSCs and young CXCR4 MSCs. The error bars represent standard error 
of the mean 
